The Phase-1 effort successfully characterized the critical components of the proposed dosimeter, specifically, the response of the scintillation material to irradiation by gamma-rays, protons, and neutrons, as well as the performance of the SSPM detector. The Phase-1 modeling studies provide a critical foundation for assessing the anticipated signals in the space radiation environment. The proposed dosimeter would overcome many of the limitations in the current generation of neutron dosimeters, and would provide baseline information on the physics, needed with the information from biological studies, to assess risk in future human-space-exploration missions to the moon and Mars.

The primary target market for the fast-neutron dosimeter is NASA missions. Key missions are NASA missions that involve extended space-time, such as possible Moon and Mars missions.

. International airlines, especially those investigating space tourism, such as Space X.

. The commercial satellite market is a large and growing market that will be interested in monitoring space radiation.

. Earth bound or terrestrial markets, including hospitals, national laboratories and industrial research, is the largest potential segment. This market does require some changes in the product design.